RibFix Advantage™ Post-Market Follow-Up

Zimmer Biomet Patient Outcome and Experience After Chest Wall Repair With RibFix Advantage™

To confirm safety, performance, and clinical benefits for the use of RibFix Advantage™ in the fixation, stabilization, and fusion of rib fractures and osteotomies of normal and osteoporotic bone

Retrospective review of subject demographic and hospital data with a prospective follow-up component evaluating clinical outcomes and quality of life for patients receiving RibFix Advantage for surgical stabilization of rib fractures from 2019 to 2021

Inclusion Criteria:

• 18-80 years of age, male or female
• Underwent reconstruction of the chest wall between February 2019 and September 2021 with RibFix Advantage™ for the fixation, stabilization, or fusion of rib fractures
• Minimum amount of follow-up data available, including one visit post-surgery
• Willing and able to sign an Informed Consent for research
• Willing and able to and complete a post-operative follow-up survey at least 3 months post-surgery

Exclusion Criteria:

• Latent or active infection with positive culture at the time of implantation
• Documented history of metal sensitivity
• Documented psychiatric condition preventing the patient from following post-op care instructions
• Fixation of the first and/or second (true) vertebrosternal rib
• Bilateral rib fractures
• Concurrent surgical procedures (i.e. splenectomy, aortic disruption repair, diaphragm injury repair, etc.) performed during the same hospitalization
• Lung injury (open pneumothorax, tension pneumothorax, hemothorax > 1L, pulmonary contusion requiring mechanical ventilation)